NCT00606268View on ClinicalTrials.gov

A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Fungal Infections
Interventions
DRUG

Micafungin

IV

Trial Locations (12)

14642

Rochester

19104

Philadelphia

23219

Richmond

38105

Memphis

46202

Indianapolis

55255

Minneapolis

60614

Chicago

77030

Houston

80218

Denver

90027

Los Angeles

92868

Orange

94304

Palo Alto

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00606268 - A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant | Biotech Hunter | Biotech Hunter